Detalles de la búsqueda
1.
Epidemiology, healthcare utilization, and related costs among patients with IPF: results from a German claims database analysis.
Respir Res
; 23(1): 62, 2022 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35305632
2.
Presence of anti-cyclic citrullinated peptide antibodies is associated with better treatment response to abatacept but not to TNF inhibitors in patients with rheumatoid arthritis: a meta-analysis.
Clin Exp Rheumatol
; 38(3): 455-466, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31770089
3.
Cost per response for abatacept versus adalimumab in patients with seropositive, erosive early rheumatoid arthritis in the US, Germany, Spain, and Canada.
Rheumatol Int
; 39(9): 1621-1630, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31240388
4.
The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease.
BMC Infect Dis
; 17(1): 45, 2017 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28061762
5.
Eliciting health state utilities for Dupuytren's contracture using a discrete choice experiment.
Acta Orthop
; 84(6): 571-8, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24286567
6.
Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry.
Arthritis Res Ther
; 21(1): 138, 2019 06 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31171024
7.
Review of regulatory recommendations for orphan drug submissions in the Netherlands and Scotland: focus on the underlying pharmacoeconomic evaluations.
Clin Ther
; 32(9): 1651-61, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20974323
Resultados
1 -
7
de 7
1
Próxima >
>>